Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
暂无分享，去创建一个
U. Mellqvist | M. Dimopoulos | Shaji K. Kumar | X. Leleu | K. Ramasamy | R. Fenk | M. Levin | F. Schjesvold | V. Doronin | H. Quach | A. Pompa | M. Darif | Cindy H. Lee | H. Sati | H. Demarquette | R. Labotka | O. Vinogradova | A. Vorog | Yolanda Gonzalez Montes | Jichang Du